AI software could help cut PET scan times in half
May 25, 2022 -- An artificial intelligence (AI) algorithm can improve image quality in half-count F-18 FDG-PET scans, a finding that paves the way for significant cuts in acquisition time in routine clinical practice, according to French researchers. Read More
FAPI-PET shows promise detecting biliary tract cancer
May 23, 2022 -- Fibroblast-activation protein inhibitor (FAPI)-PET imaging proved to be superior to current methods such as FDG-PET for staging patients with biliary tract tumors for surgery in a study published May 17 in Radiology. Read More
PET/MRI provides new insights into knee osteoarthritis
May 19, 2022 -- PET/MRI has identified which compartments of the knee may be the best targets for new treatments for early osteoarthritis, according to a study published May 16 in Clinical Radiology. Read More
Brigham and Women's gets FDA warning letter on PET tracers
May 18, 2022 -- Brigham and Women's Hospital in Boston has responded to a recent warning letter it received from the U.S. Food and Drug Administration (FDA) regarding "significant violations" at its facility for producing PET radiotracers. Read More
SNMMI updates guidelines on PSMA-PET imaging
May 13, 2022 -- The Society for Nuclear Medicine and Molecular Imaging (SNMMI) is now considering all PSMA-PET radiotracers for detecting prostate cancer -- whether approved or not -- as equivalent, and it will refer to them as a class ("PSMA PET"), according to a recent update of the society's Appropriate Use Criteria. Read More
PET/CT reveals heart artery inflammation in COVID-19 patients
May 6, 2022 -- PET/CT imaging shows that inflammation of the aorta is increased in the early postinfection stage of COVID-19 in patients with severe disease, according to a study published May 2 in the Journal of Nuclear Cardiology. Read More
Imaging criteria helps pick best patients for Pluvicto treatment
May 3, 2022 -- What's the best way to pick which patients should receive treatment with Pluvicto, a recently approved radiopharmaceutical therapy for metastatic prostate cancer? Imaging criteria can help select the best candidates, according to a presentation May 2 at the American Roentgen Ray Society meeting in New Orleans. Read More
Use of V/Q scans dropped during COVID-19 pandemic
May 3, 2022 -- Nuclear medicine ventilation/perfusion scintigraphy (V/Q) dropped significantly during the COVID-19 pandemic, as hospitals took up new protocols to reduce the chances of infections, according to an abstract presented at the American Roentgen Ray Society meeting in New Orleans. Read More
PET tracer shows promise imaging high cholesterol activity
May 2, 2022 -- A new PET radiotracer is safe for humans and could provide a noninvasive approach for diagnosing aldosteronism, a condition linked to high cholesterol and heart disease, according to a study published April 28 in the Journal of Nuclear Medicine. Read More
PET-based model may help stage Alzheimer's disease patients
April 28, 2022 -- Researchers have developed a new model for diagnosing the severity of Alzheimer's disease in patients based largely on the spatial topography of brain PET imaging, according to a study published April 25 in Nature Aging. Read More
Special Feature
SNMMI warns of omicron's impact on PET/CT scans

The COVID-19 omicron variant appears to cause an unusual imaging pattern on FDG-PET/CT scans in cancer patients, according to a statement from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) COVID-19 Task Force. Read more

Diagnostic Imaging Update on Kauai
June 27 - July 1
Kauai, Hawaii United States
Imaging in Hawaii
July 18-21
Kapalua, Hawaii United States
34th Eastern Neuroradiological Society (ENRS) 2022 Annual Meeting
August 18-21
Burlington, Vermont United States
World Molecular Imaging Congress (WMIC)
September 28 - October 1
Miami, Florida United States